Monoamine Oxidase Inhibitors (Maois) + Levomilnacipran Hydrochloride Interaction
Contraindicatedinteraction on record
Description
Concomitant use increases risk of serotonin syndrome. Contraindicated with MAOIs intended to treat psychiatric disorders or within 14 days of stopping MAOI treatment.
Mechanism
Increased serotonergic activity leading to serotonin syndrome
Source: NLP:levomilnacipran hydrochloride